Measles and stroke show why healthcare must innovate

With large cohorts of children and teenagers unvaccinated against measles, mumps, and rubella, health systems have been playing catch up as measles cases soar. Corrigan and colleagues look at seven innovative approaches to reducing the burden of such diseases, including widespread uptake of the poly...

Full description

Saved in:
Bibliographic Details
Published inBMJ (Online) Vol. 346; no. may01 1; p. f2819
Main Author Jackson, Trevor
Format Journal Article
LanguageEnglish
Published London British Medical Journal Publishing Group 01.05.2013
BMJ Publishing Group LTD
Subjects
Chronic illnesses
Diabetes
Innovations
Measles
Medical innovations
Prescription drugs
Public health
United Kingdom > UK
England
Wales
Online AccessGet full text

Cover

More Information
Summary:With large cohorts of children and teenagers unvaccinated against measles, mumps, and rubella, health systems have been playing catch up as measles cases soar. Corrigan and colleagues look at seven innovative approaches to reducing the burden of such diseases, including widespread uptake of the polypill (containing aspirin, a statin, and folic acid), an idea that was launched in the BMJ a decade ago (BMJ 2003;326:1427). A paper by Douglas and colleagues finds an association between orlistat, the only prescription drug available to treat obesity, and abnormalities in liver function (doi: 10.1136/bmj.f1936 ).
Bibliography:href:bmj-346-bmj-f2819.pdf
Related-article-href:10.1136/bmj.f1936
Related-article-href:10.1136/bmj.f1699
local:bmj;346/may01_1/f2819
Related-article-href:10.1136/bmj.f2695
istex:FAACE2F31DCBD8349D4373DB895947E1FDF19B33
ArticleID:choice040513
ark:/67375/NVC-ZJM5FM16-X
Related-article-href:10.1136/bmj.f2793
ISSN:0959-8138
1756-1833
1756-1833
DOI:10.1136/bmj.f2819